Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
Numerate
TARA Biosystems |
| gptkbp:CEO |
gptkb:David_Berry
|
| gptkbp:focus |
gptkb:artificial_intelligence
gptkb:machine_learning drug discovery |
| gptkbp:foundedYear |
2019
|
| gptkbp:headquartersLocation |
gptkb:Boston,_Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Valo Health
|
| gptkbp:industry |
gptkb:biotechnology
pharmaceuticals |
| gptkbp:notableEvent |
announced plans to go public via SPAC in 2021
|
| gptkbp:notableProduct |
Opal Computational Platform
|
| gptkbp:parentCompany |
gptkb:Flagship_Pioneering
|
| gptkbp:website |
https://www.valohealth.com/
|
| gptkbp:bfsParent |
gptkb:Koch_Disruptive_Technologies
|
| gptkbp:bfsLayer |
6
|